---
title: Peptide CDMOs in China
path: /modalities/peptide/china
companies_count: 9
---

# Peptide CDMOs in China

9 published CDMOs match Peptide in China.

Locations in this set include China, United States, United Kingdom, Mexico, Singapore, and Switzerland.

Capabilities that show up most often in this set: CMC Analytical Development, API Synthesis & Manufacturing, Process Development, CMC Regulatory Submission Support, and Sterile Fill-Finish & Aseptic Manufacturing.

## Matching companies

- [Boston Institute of Biotechnology, LLC](/companies/bostonbib)
  - Full-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy manufacturing from preclinical to commercial scale, with bioreactor capacity up to 50,000L.
- [HitGen Inc.](/companies/hitgen)
  - HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.
- [JYMed Peptide](/companies/jymedtech)
  - Peptide CDMO offering custom synthesis from milligrams to metric tons, with 13 cGMP lines and FDA-, NMPA- and EDQM-approved sites. Provides peptide API manufacturing plus syringe, cartridge and lyophilized finished-dose filling at its Shenzhen site.
- [PharmaBlock](/companies/pharmablock)
  - Leading provider of innovative chemistry products and services for pharmaceutical R&D and commercial manufacturing, with expertise in process development, GMP manufacturing, and low-carbon chemistry solutions.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Piramal Pharma Solutions](/companies/piramalpharmasolutions)
  - CDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management.
- [Porton](/companies/portonpharma)
  - Porton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies.
- [Stevanato Group](/companies/stevanatogroup)
  - Leading global provider of integrated drug containment, drug delivery, and diagnostic solutions with 75+ years' experience in glass primary packaging, contract manufacturing, and analytical services across development, clinical, and commercial stages.
- [重庆兴泰濠制药有限公司 (Sintaho)](/companies/sintaho)
  - China-based API and CDMO/CMO supplier focused on cytotoxic and OEB5 high-potency APIs, peptides, and XDC compounds. Reports FDA on-site inspections in 2024 and 2025 and product registrations in more than 30 countries.